GLYCYRRHIZINE (CAS: 1405-86-3) MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-3884 |   Chemical and Material

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Glycyrrhizine (CAS: 1405-86-3) Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL GLYCYRRHIZINE (CAS: 1405-86-3) MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL GLYCYRRHIZINE (CAS: 1405-86-3) MARKET

7.1 GLOBAL GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA GLYCYRRHIZINE (CAS: 1405-86-3) MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 MAFCO Worldwide

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Gansu Yalan Pharmaceutical

16.3 Qingdao Taitong Pharmaceutical

16.4 FAME Pharmaceuticals Industry

16.5 Fanzhi Group

16.6 Cokey

16.7 Minophagen Pharmaceutical

16.8 Alps Pharmaceutical

16.9 Hunan Dinuo Pharmaceutical

16.10 Ruihong Bio-technique

16.11 Lion Corporation

16.12 ELION Group

16.13 Tiansheng Pharmaceutical

16.14 Xinjiang Kunlunshengnong

16.15 Xinjiang TIANSHAN Pharmaceuticals Industry

16.16 Shaanxi Fujie Pharmaceutical

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

Major Types Covered
Low Purity
High Purity

Major Downstream Industry Covered
Others
Pharmaceuticals
Food Industry

Companies

MAFCO Worldwide
Gansu Yalan Pharmaceutical
Qingdao Taitong Pharmaceutical
FAME Pharmaceuticals Industry
Fanzhi Group
Cokey
Minophagen Pharmaceutical
Alps Pharmaceutical
Hunan Dinuo Pharmaceutical
Ruihong Bio-technique
Lion Corporation
ELION Group
Tiansheng Pharmaceutical
Xinjiang Kunlunshengnong
Xinjiang TIANSHAN Pharmaceuticals Industry
Shaanxi Fujie Pharmaceutical

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.